Systemic levels contribute significantly to increased intraocular IGF-I, IGF-II and IFG-BP3 in proliferative diabetic retinopathy

Hormone and Metabolic Research

Volumn 32, Issue 5, 2000, Pages 196-200

  Spranger, J ^a   Buhnen J ^a   Jansen, V ^a   Krieg, M ^a   Meyer Schwickerath, R ^b   Blum, W F ^c   Schatz, H ^a   Pfeiffer, A F H ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c Endokrinologisches Labor   (Germany)

Author keywords

Anglogenesis; Cytokines; Diabetes; Growth Factors; Retinopathy

Indexed keywords

CYTOKINE; GROWTH FACTOR; SERUM ALBUMIN; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN C;

ANGIOGENESIS; ARTICLE; BLOOD LEVEL; BLOOD RETINA BARRIER; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIABETIC RETINOPATHY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; VITREOUS BODY;

EID: 0034096960     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978621     Document Type: Article

References (21)

1. 1 Grant M, Russell B, Fitzgerald C, Merimee TJ. Insulin-like growth factors in the vitreous: studies in control and diabetic subjects with neovascularisation. Diabetes 1986; 35: 416-420
2. 2 Meyer-Schwickerath R, Pfeiffer A, Blum WF, Freyberger H, Klein M, Losche C, Rollmann R, Schatz H. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects. J Clin Invest 1993; 92: 2620-2625
3. 3 Aiello LP, Avery RL, Arigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. New Engl J Med 1994; 331: 1480-1487
4. 4 Poulsen JD. Diabetes and anterior pituitary deficiency. Diabetes 1953; 2: 7-12
5. 5 Sharp PS, Fallon TJ, Brazier J, Sandler LM, Joplin GF, Kohner EM. Long term follow-up of patients who underwent yttrium-90 pituitary implantation for treatment of proliferative diabetic retinopathy. Diabetologia 1987; 30: 199-207
6. 6 Merimee TJ, Fineberg SE, McKusick VA, Hall J. Diabetes mellitus and sexual ateliotic dwarfism: a comparative study. J Clin Invest 1970; 49: 1096-1102
7. 7 Merimee TJ. A follow-up study of vascular disease in growth hormone deficient dwarfs with diabetes. N Engl J Med 1978; 298: 1217-1222
8. 8 Dills DG, Moss SE, Klein R, Klein BEK. Association of elevated IGF-1 levels with increased retinopathy in late onset diabetes. Diabetes 1991; 40: 1725-1730
9. 9 Lamberton PR, Goodman AD, Dasoff A, Rubin CL, Treble DH, Saba TM, Merimee TJ, Dodds JW. Von Willebrand factor, fibronectin and insulin-like growth factors I and II in diabetic retinopathy and nephropathy. Diabetes 1984; 33: 125-129
10. 10 Hyer SL, Sharp PS, Brooks RA, Burrin JM, Kohner EM. Serum IGF-1 concentration in diabetic retinopathy. Diabet Med 1988; 5: 356-360
11. 11 Chantelau E. Rapidly progressing diabetic retinopathy upon improved metabolic control. J Diab Comp 1993; 7: 63-64
12. 12 Hyer SL, Sharp PS, Brooks RA, Burrin JM, Kohner EM. A two-year follow-up study of insulin-like growth factor-I in diabetic retinopathy. Metabolism 1989; 38: 586-589
13. 13 Dunger DB. Insulin and insulin-like growth factors in diabetes mellitus. Arch Dis Child 1995; 72: 469-471
14. 14 Chew EY, Mills JL, Metzger BE, Remaley NA. Jovanovic-Peterson L, Knopp RH, Conley M, Lawrence R, Simpson JL, Holmes LB, Aarons JH. Diabetes in early Pregnancy Study: Metabolic control and progression of retinopathy. Diab Care 1995; 18 (5): 631-637
15. 15 Smith LEH, Kopchick JJ, Chen W, Knapp J, Kinose F, Daley D, Foley E, Smith RG, Schaeffer JM. Essential role of growth hormone in ischemia-induced retinal neovascularization. Science 1997; 276: 1706-1709
16. 16 Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich JR. A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin binding protein: its use for diagnosis of growth hormone deficiency. J Clin Endocrinol Metab 1990; 70: 1292-1298
17. 17 McAvoy JW, Chamberlain CG. Growth factors in the eye. Prog Growth Factor Res 1990; 2: 29-43
18. 18 Henricsson M, Berntorp K, Berntorp E, Fernlund P, Sundkvist G. Progression of retinopathy after improved metabolic control in type 2 diabetic patients. Relation to IGF-1 and hemostatic variables. Diabetes Care 1999; 22: 1944-1949
19. 19 Hussain MA, Studer K, Messmer EP, Froesch ER. Treatment with insulin-like growth factor I alters capillary permeability in skin and retina. Diabetes 1995; 44: 1209-1212
20. 20 Smith LE, Shen W, Perruzzi C, Soker S, Kinose F, Xu X, Robinson G, Driver S, Bischoff J, Zhang B, SchaefferJM, Senger DR. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med 1999; 5: 1390-1395
21. 21 The Diabetes Control and Complications Trial Research Group. Early worsening of diabetic retinopathy in the Diabetes Control and Complication Trial. Arch Ophthalmol 1998; 116: 874-886